EE200000211A - Rasestumise vältimise meetod ja rasestumisvastase vahendi komplekt - Google Patents

Rasestumise vältimise meetod ja rasestumisvastase vahendi komplekt

Info

Publication number
EE200000211A
EE200000211A EEP200000211A EEP200000211A EE200000211A EE 200000211 A EE200000211 A EE 200000211A EE P200000211 A EEP200000211 A EE P200000211A EE P200000211 A EEP200000211 A EE P200000211A EE 200000211 A EE200000211 A EE 200000211A
Authority
EE
Estonia
Prior art keywords
contraception
contraceptive kit
contraceptive
kit
Prior art date
Application number
EEP200000211A
Other languages
English (en)
Inventor
Jay Gast Michael
Paul Miller Christopher
Original Assignee
American Home Products Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corporation filed Critical American Home Products Corporation
Publication of EE200000211A publication Critical patent/EE200000211A/et
Publication of EE04092B1 publication Critical patent/EE04092B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200000211A 1997-11-06 1998-11-04 Rasestumisvastase vahendi komplekt EE04092B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96508397A 1997-11-06 1997-11-06
PCT/US1998/023427 WO1999024027A2 (en) 1997-11-06 1998-11-04 Anti-estrogen plus progestin containing oral contraceptives

Publications (2)

Publication Number Publication Date
EE200000211A true EE200000211A (et) 2001-04-16
EE04092B1 EE04092B1 (et) 2003-08-15

Family

ID=25509417

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000211A EE04092B1 (et) 1997-11-06 1998-11-04 Rasestumisvastase vahendi komplekt

Country Status (28)

Country Link
EP (1) EP1051179B1 (et)
JP (1) JP2001522798A (et)
CN (1) CN1278732A (et)
AR (1) AR016667A1 (et)
AT (1) ATE304359T1 (et)
AU (2) AU760540B2 (et)
BG (1) BG104451A (et)
BR (1) BR9813982A (et)
CA (1) CA2307210A1 (et)
CZ (1) CZ294155B6 (et)
DE (1) DE69831605T2 (et)
DK (1) DK1051179T3 (et)
EA (1) EA200000492A1 (et)
EE (1) EE04092B1 (et)
ES (1) ES2246541T3 (et)
GE (1) GEP20043290B (et)
HR (1) HRP20000269A2 (et)
HU (1) HUP0100293A3 (et)
ID (1) ID24568A (et)
IL (1) IL135621A0 (et)
NO (1) NO20002167L (et)
NZ (1) NZ503890A (et)
PL (1) PL340623A1 (et)
SK (1) SK6482000A3 (et)
TR (1) TR200001268T2 (et)
UA (1) UA68365C2 (et)
WO (1) WO1999024027A2 (et)
ZA (1) ZA9810136B (et)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120263A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to prevent bone loss-progesterone and estrogen agonists
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
UA66861C2 (uk) * 1998-05-15 2004-06-15 Уайт 2-феніл-1-[4-(2-аміноетокси)бензил]індол в комбінації з естрогенами, способи лікування та продукт для лікування
US6380166B1 (en) 1999-09-13 2002-04-30 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
WO2001019839A1 (en) * 1999-09-13 2001-03-22 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols
US6376486B1 (en) * 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
WO2003011282A1 (en) 2001-07-31 2003-02-13 Pfizer Products Inc. Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
EP1809602B1 (en) 2004-10-27 2008-10-29 Janssen Pharmaceutica N.V. Indole derivatives useful as progesterone receptor modulators
FR2880625B1 (fr) * 2005-01-07 2007-03-09 Sanofi Aventis Sa Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
UY29527A1 (es) * 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
DE102008057230A1 (de) * 2008-11-11 2010-05-12 Bayer Schering Pharma Aktiengesellschaft Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin
EP2580210B1 (en) 2010-06-10 2017-03-01 Seragon Pharmaceuticals, Inc. Estrogen receptor modulators and uses thereof
US9187460B2 (en) 2011-12-14 2015-11-17 Seragon Pharmaceuticals, Inc. Estrogen receptor modulators and uses thereof
AU2016331065B2 (en) 2015-10-01 2021-04-29 Olema Pharmaceuticals, Inc. Tetrahydro-1H-pyrido(3,4-b)indole anti-estrogenic drugs
EP3386968A4 (en) 2015-12-09 2019-09-25 The Board of Trustees of the University of Illinois BENZOTHIOPHEN-BASED SELECTIVE ESTROGEN RECEPTOR-DOWN-REGULATING PREPARATIONS
EP3455218A4 (en) 2016-05-10 2019-12-18 C4 Therapeutics, Inc. C3 CARBON-BASED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN REDUCTION
EP3454856A4 (en) 2016-05-10 2019-12-25 C4 Therapeutics, Inc. HETEROCYCLIC DEGRONIMERS FOR TARGET PROTEIN REDUCTION
WO2017197036A1 (en) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. Spirocyclic degronimers for target protein degradation
CN109789143A (zh) 2016-07-01 2019-05-21 G1治疗公司 基于嘧啶的抗增殖剂
WO2018081168A2 (en) 2016-10-24 2018-05-03 The Board Of Trustees Of The University Of Illinois Benzothiophene-based selective mixed estrogen receptor downregulators
BR112019013814A2 (pt) 2017-01-06 2020-01-21 G1 Therapeutics Inc método para tratamento de câncer ou de um tumor em um indivíduo, composição farmacêutica, combinação, e, kit.
AU2018217809A1 (en) 2017-02-10 2019-08-22 G1 Therapeutics, Inc. Benzothiophene estrogen receptor modulators
WO2019006393A1 (en) 2017-06-29 2019-01-03 G1 Therapeutics, Inc. MORPHIC FORMS OF GIT38 AND METHODS OF MAKING SAME
CN113453679A (zh) 2018-12-20 2021-09-28 C4医药公司 靶向蛋白降解
WO2024030968A1 (en) 2022-08-03 2024-02-08 Brystol-Myers Squibb Company Compounds for modulating ret protein
WO2024097989A1 (en) 2022-11-04 2024-05-10 Bristol-Myers Squibb Company Ret-ldd protein degraders
WO2024097980A1 (en) 2022-11-04 2024-05-10 Bristol-Myers Squibb Company Ret-ldd protein inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA716118B (en) * 1970-10-05 1972-05-31 Richardson Merrell Inc Contraception
ZA9510926B (en) * 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
IL120266A (en) * 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
IL120263A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to prevent bone loss-progesterone and estrogen agonists
DK0802183T3 (da) * 1996-04-19 2002-02-04 American Home Prod Østrogenforbindelser
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive

Also Published As

Publication number Publication date
SK6482000A3 (en) 2000-11-07
ATE304359T1 (de) 2005-09-15
AU760540B2 (en) 2003-05-15
WO1999024027A3 (en) 1999-07-15
UA68365C2 (en) 2004-08-16
CN1278732A (zh) 2001-01-03
BR9813982A (pt) 2000-09-26
NO20002167L (no) 2000-06-28
ZA9810136B (en) 2000-05-05
GEP20043290B (en) 2004-07-26
EP1051179B1 (en) 2005-09-14
BG104451A (en) 2000-12-29
EE04092B1 (et) 2003-08-15
CZ20001661A3 (cs) 2000-12-13
WO1999024027A2 (en) 1999-05-20
ID24568A (id) 2000-07-27
HUP0100293A3 (en) 2002-12-28
DK1051179T3 (da) 2005-10-31
NO20002167D0 (no) 2000-04-27
TR200001268T2 (tr) 2001-01-22
EA200000492A1 (ru) 2000-10-30
JP2001522798A (ja) 2001-11-20
CZ294155B6 (cs) 2004-10-13
HRP20000269A2 (en) 2000-12-31
AR016667A1 (es) 2001-07-25
DE69831605T2 (de) 2006-06-14
AU2003204896B2 (en) 2006-06-15
EP1051179A2 (en) 2000-11-15
PL340623A1 (en) 2001-02-12
CA2307210A1 (en) 1999-05-20
IL135621A0 (en) 2001-05-20
DE69831605D1 (de) 2005-10-20
NZ503890A (en) 2002-08-28
ES2246541T3 (es) 2006-02-16
AU1303199A (en) 1999-05-31
HUP0100293A2 (hu) 2001-10-28

Similar Documents

Publication Publication Date Title
EE200000211A (et) Rasestumise vältimise meetod ja rasestumisvastase vahendi komplekt
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
EE9600194A (et) Isekleepuv mark ja meetod selle valmistamiseks
NO975759D0 (no) Inokuleringsmiddel og fremgangsmåte for fremstilling av inokuleringsmiddel
DE69835020D1 (de) Plasmabrenner und verwendungsverfahren dieses plasmabrenners
FI973750A0 (fi) 2-metyylitienobentsodiatsepiinin valmistus ja kiteiset muodot
DK1041879T3 (da) Desinfektionsmiddel og fremstillingsmetode
NO972125D0 (no) Hemmoroideblandinger og fremgangsmåte for anvendelse
ID27859A (id) Tampon dan metoda pembuatannya
FI962055A (fi) Pariston jatkolaite ja siihen liittyvä menetelmä
FI980246A (fi) Menetelmä keittimen käyttämiseksi ja keitin
DK1334725T3 (da) Östroprogestativt antikonceptionsmiddel
PT826679E (pt) Compostos de naftilo intermediarios composicoes e metodos de utilizacao
KR960007085U (ko) 콘돔
DE29700260U1 (de) Kondom
DE29506326U1 (de) Kondom
DE29618505U1 (de) Kondom
FIU960163U0 (fi) TV-kondomi ja TV-tamponipolariteetti ehkäisymenetelmätekniikka
DE29605563U1 (de) Präservativ
KR970060686U (ko) 조루 방지 콘돔
KR970006219A (ko) 셀화된 무기질 바디 및 이의 제조방법
KR960016352U (ko) 콘돔
KR960016351U (ko) 콘돔
DE29501643U1 (de) Kondom
KR970020851U (ko) 콘돔

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

MM4A Lapsed by not paying the annual fees

Effective date: 20051104